Therillia Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 1

Therillia General Information

Description

Developer of novel drug candidates designed to provide proof of concept strategies from pre-clinical to clinical stage. The company's drug candidate identifies potential responder patient populations, rational drug combinations, and the utility of clinical biomarkers, enabling sustainable biopharmaceutical companies to reduce the time and cost of achieving proof of concept data for important new therapeutics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 1010 Sherbrooke Street West
  • Suite 408
  • Montreal, Quebec H3A 2R7
  • Canada
+1 (514) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Therillia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Startup
To view Therillia’s complete valuation and funding history, request access »

Therillia Executive Team (6)

Name Title Board Seat Contact Info
Michael Dixon Chief Executive Officer, President & Board Member
Ramy Hobeika Controller
Rosa Pierro Executive
Gordon Shore Ph.D Chief Scientific Officer
Pierre Beauparlant Ph.D Chief Business Officer
You’re viewing 5 of 6 executive team members. Get the full list »

Therillia Board Members (4)

Name Representing Role Since
Jean Lamarre Therillia Board Member 000 0000
Michael Dixon Therillia Chief Executive Officer, President & Board Member 000 0000
Pierre Johnson MD Self Chairman 000 0000
Robert Mcneil Ph.D Sanderling Ventures Board Member 000 0000
To view Therillia’s complete board members history, request access »

Therillia Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Sanderling Ventures Venture Capital Majority 000 0000 000000 0
To view Therillia’s complete investors history, request access »

Therillia Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000000000 18-Apr-2019 000000000000000000 Biotechnology
To view Therillia’s complete acquisitions history, request access »

Therillia Subsidiaries (1)

Company Name Industry Location Founded
00000 000000000000 Biotechnology Montreal, Canada 0000
To view Therillia’s complete subsidiaries history, request access »